Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial

IMPORTANCE: Panretinal photocoagulation (PRP) is standard treatment for reducing severe visual loss from proliferative diabetic retinopathy (PDR). However, PRP can damage the retina, resulting in peripheral vision loss or worsening diabetic macular edema (DME). OBJECTIVE: Compare ranibizumab versus...

全面介紹

Na minha lista:
書目詳細資料
發表在:JAMA
Main Authors: Gross, Jeffrey G., Glassman, Adam R., Jampol, Lee M., Inusah, Seidu, Aiello, Lloyd Paul, Antoszyk, Andrew N., Baker, Carl W., Berger, Brian B., Bressler, Neil M., Browning, David, Elman, Michael J., Ferris, Frederick L., Friedman, Scott M., Marcus, Dennis M., Melia, Michele, Stockdale, Cynthia R., Sun, Jennifer K., Beck, Roy W.
格式: Artigo
語言:Inglês
出版: 2015
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5567801/
https://ncbi.nlm.nih.gov/pubmed/26565927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2015.15217
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍